European Stocks That May Be Trading Below Fair Value In July 2026

Simply Wall St · 2d ago

As European markets grapple with volatility, the pan-European STOXX Europe 600 Index ended a turbulent week relatively unchanged, reflecting investor caution amid fluctuating tech stocks and geopolitical tensions. In this environment, identifying stocks that may be trading below their fair value can present opportunities for investors seeking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est)
VIGO Photonics (WSE:VGO) PLN487.00 PLN963.94 49.5%
Mips (OM:MIPS) SEK378.00 SEK745.85 49.3%
Hiab Oyj (HLSE:HIAB) €53.65 €106.37 49.6%
Hemnet Group (OM:HEM) SEK85.45 SEK168.84 49.4%
ERAMET (ENXTPA:ERA) €42.18 €83.52 49.5%
Endomines Finland Oyj (HLSE:PAMPALO) €7.92 €15.47 48.8%
Deutsche Beteiligungs (XTRA:DBAN) €21.85 €43.50 49.8%
Com.Tel (BIT:CMTL) €1.87 €3.70 49.5%
Casta Diva Group (BIT:CDG) €3.05 €6.05 49.6%
Cambi (OB:CAMBI) NOK21.50 NOK42.54 49.5%

Click here to see the full list of 200 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Exosens (ENXTPA:EXENS)

Overview: Exosens, along with its subsidiaries, is engaged in the development, manufacturing, and sale of electro-optical technologies across France, Europe, North America, Asia, and other international markets with a market capitalization of €2.99 billion.

Operations: The company generates revenue from two key segments: Amplification, contributing €319.20 million, and Detection and Imaging, which accounts for €150.50 million.

Estimated Discount To Fair Value: 27.3%

Exosens appears undervalued based on cash flows, trading at €59.1, below its estimated future cash flow value of €81.3, offering a discount of over 20%. Recent developments include securing a major contract with BROLIS for image intensifier tubes and obtaining a €140 million financing facility from the European Investment Bank to support innovation in defense technologies. The company's earnings are forecast to grow faster than the French market, enhancing its financial outlook.

ENXTPA:EXENS Discounted Cash Flow as at Jul 2026
ENXTPA:EXENS Discounted Cash Flow as at Jul 2026

Borregaard (OB:BRG)

Overview: Borregaard ASA is a company that develops, produces, and markets specialized biochemicals and biomaterials globally, with a market cap of NOK16.10 billion.

Operations: The company's revenue segments include Bio Materials at NOK2.76 billion, Bio Solutions at NOK4.29 billion, and Fine Chemicals at NOK741 million.

Estimated Discount To Fair Value: 43.2%

Borregaard is trading at NOK 161.6, significantly below its estimated future cash flow value of NOK 284.53, indicating it is undervalued by over 20%. Despite a recent net loss in Q2 and reduced profit margins from last year, earnings are forecast to grow substantially at 54.7% annually, outpacing the Norwegian market. The company has initiated a share repurchase program and anticipates increased sales volumes in BioMaterials for the remainder of the year.

OB:BRG Discounted Cash Flow as at Jul 2026
OB:BRG Discounted Cash Flow as at Jul 2026

Nordex (XTRA:NDX1)

Overview: Nordex SE, with a market cap of €9.79 billion, develops, manufactures, and distributes multi-megawatt onshore wind turbines across Europe, North America, Latin America, and internationally.

Operations: Nordex SE generates its revenue primarily through the development, manufacturing, and distribution of multi-megawatt onshore wind turbines across various regions including Europe, North America, and Latin America.

Estimated Discount To Fair Value: 15.2%

Nordex, trading at €41.4, is slightly undervalued relative to its future cash flow value of €48.84. Recent earnings growth was very large over the past year, and while revenue is forecast to grow slower than 20% annually, it will still outpace the German market's growth rate. Nordex has secured multiple new orders across Europe and North America, including a significant project in Romania, enhancing its renewable energy footprint and supporting long-term cash flow stability through service agreements.

XTRA:NDX1 Discounted Cash Flow as at Jul 2026
XTRA:NDX1 Discounted Cash Flow as at Jul 2026

Taking Advantage

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.